Latest News
Select the category
Scancell Receives FDA Fast Track Designation for iSCIB1+
Interim Results and Business Update
Scancell announces FDA clearance of IND application for global Phase 3 trial of iSCIB1+ in advanced melanoma
Notice of Interim Results and Investor Presentation
Scancell updated Phase 2 data shows continued improvement in progression free survival with iSCIB1+
Scancell to present positive Phase 2 data on Immunobody® iSCIB1+ in late-stage melanoma at SITC 2025
No results found.
Regulatory News Archive
JOIN OUR MAILING LIST
Sign up for news updates to stay up to date with Scancell.